Модификация и валидация лабораторного метода определения активности L-аспарагиназы в сыворотке крови пациентов

А. И. Осипьянц, Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), О. М. Тумутолова(National Research Mordovia State University), А. Б. Шикалов, А И Карачунский, Е. В. Блинова(Physical Sciences (United States)), Д. Н. Шимановский
Химико-фармацевтический журнал
March 4, 2023
10.30906/0023-1134-2023-57-2-58-60
Cited by 0

Related Papers

Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13
Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model
|Biochemical and Biophysical Research Communications|2025|12